CS
OM icon

Credit Suisse’s Outset Medical OM Stock Holding History

Credit Suisse’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,875
Closed -$469K – 3117
2023
Q3 		$469K Sell
2,875
-158
-5% -$37.3K ﹤0.01% 2713
2023
Q2 		$995K Sell
3,033
-355
-10% -$108K ﹤0.01% 2383
2023
Q1 		$935K Buy
3,388
+119
+4% +$43.7K ﹤0.01% 2373
2022
Q4 		$1.27M Buy
3,269
+909
+39% +$256K ﹤0.01% 2176
2022
Q3 		$564K Sell
2,360
-65
-3% -$17.4K ﹤0.01% 2716
2022
Q2 		$540K Buy
2,425
+9
+0.4% +$3.87K ﹤0.01% 2794
2022
Q1 		$1.65M Buy
2,416
+415
+21% +$250K ﹤0.01% 2215
2021
Q4 		$1.38M Buy
2,001
+356
+22% +$263K ﹤0.01% 3068
2021
Q3 		$1.22M Buy
1,645
+99
+6% +$67.5K ﹤0.01% 3175
2021
Q2 		$1.16M Buy
1,546
+1,115
+259% +$852K ﹤0.01% 3276
2021
Q1 		$351K Buy
+431
New +$333K ﹤0.01% 3944

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Credit Suisse's OM Position: Q4 2023 in Review

Credit Suisse sold out of Outset Medical (OM) in Q4 2023, closing a stake of 2,875 shares — an estimated $469K sold.

Credit Suisse first reported a position in OM in Q1 2021 and held it in 11 quarters. The position peaked at $1.65M in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Credit Suisse reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 2,875 Outset Medical shares in Q4 2023, an estimated $469K.
  • Credit Suisse first reported a position in Outset Medical in Q1 2021 and held it in 11 quarters.
  • Credit Suisse's Outset Medical position peaked at $1.65M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.